HopeStage
Back to all studies
WithdrawnNCT04311619

Does rTMS Induce Synaptic Plasticity?

Medication studyAges 18–70United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
Palo Alto and 1 more locationSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2019
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Davidzon, Guido, M.D.
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Device, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT04311619
Official title
Show the full official title

Does Repetitive Transcranial Magnetic Stimulation (rTMS) Induce Synaptic Plasticity?

Recruitment & locations

Withdrawn

Palo Alto · Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Davidzon, Guido, M.D.

Does this study involve medication?

Yes. The study involves medication, including [11C]UCB-J radiotracer.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies